Tirzepatide represents a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://margievzhp858777.dailyhitblog.com/46181292/tirzepatide-a-new-frontier-in-diabetes-treatment